Spigen Korea슈피겐코리아
192440 · KOSDAQ · ₩192440 · 슈피겐코리아
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩101,908
vs the current price (₩27,500)
- Enterprise value
- ₩436B
- Equity value
- ₩633B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 271% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩27,500, the model needs an operating margin of 2.3% every year (it uses 9.1%).
- 35% of the last 12 months' net profit came from outside operations (stakes in other companies, interest, one-offs). The model adds those stakes at book value but doesn't project that income.
- Today's P/E is 3.3× against a typical 5.2× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩69,389
- +152.3%
- Base
- ₩101,908
- +270.6%
- Bull
- ₩159,497
- +480.0%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (9.1%).
Revenue growth
- 1.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.3% a year, annual reports), fading to 3% by year 5.
- 1.7%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.3% a year, annual reports), fading to 3% by year 5.
- 2.2%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.3% a year, annual reports), fading to 3% by year 5.
- 2.6%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.3% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (1.3% a year, annual reports), fading to 3% by year 5.
Business
- 9.1%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 9.6%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 12.1%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 30.8%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.22, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩482B
- Net debt (borrowings and leases − cash and deposits)
- −₩154B
- + Stakes and investments
- ₩45B
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩1.3B
- Shares
- 6,216,363
- Share price
- ₩27,500
- Market cap
- ₩171B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩447B | ₩465B | ₩464B | ₩489B | ₩497B | ₩508B | ₩521B | ₩537B |
| Growth | 0.3% | 4.0% | −0.3% | 1.3% | 1.7% | 2.2% | 2.6% | 3.0% |
| EBIT | ₩35B | ₩22B | ₩33B | ₩44B | ₩45B | ₩46B | ₩47B | ₩49B |
| EBIT margin | 7.9% | 4.7% | 7.2% | 9.1% | 9.1% | 9.1% | 9.1% | 9.1% |
| After-tax EBIT | ₩26B | ₩16B | ₩24B | ₩32B | ₩33B | ₩34B | ₩34B | ₩35B |
| + Depreciation | — | — | — | ₩47B | ₩48B | ₩49B | ₩50B | ₩52B |
| − Capital spending | ₩82B | ₩74B | ₩9.4B | ₩59B | ₩60B | ₩61B | ₩63B | ₩65B |
| − Working capital | ₩6.6B | ₩36B | −₩2.9B | ₩1.9B | ₩2.6B | ₩3.4B | ₩4.1B | ₩4.8B |
| Free cash flow | — | — | — | ₩18B | ₩18B | ₩17B | ₩17B | ₩17B |
| Discount factor | — | — | — | 0.932 | 0.868 | 0.809 | 0.754 | 0.703 |
| Present value | — | — | — | ₩17B | ₩15B | ₩14B | ₩13B | ₩12B |
Terminal value ₩518B, worth ₩364B today: 84% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩92,256 a share)Now 0.30× | ₩25,1470.27× | ₩37,2920.40× | ₩61,7000.67× |
| Price / earnings (last 12 months: ₩8,399 a share)Now 3.27× | ₩36,5934.36× | ₩43,9365.23× | ₩52,3426.23× |
| P/E on run-rate earnings (Q2 2026 × 4: ₩9,799 a share)Now 2.81× | ₩42,6934.36× | ₩51,2595.23× | ₩61,0666.23× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | ₩108,149 | ₩113,140 | ₩119,267 | ₩126,977 | ₩136,989 |
| 6.8% | ₩101,075 | ₩104,980 | ₩109,678 | ₩115,443 | ₩122,698 |
| 7.3% | ₩95,135 | ₩98,238 | ₩101,908 | ₩106,321 | ₩111,738 |
| 7.8% | ₩90,079 | ₩92,576 | ₩95,487 | ₩98,929 | ₩103,069 |
| 8.3% | ₩85,726 | ₩87,757 | ₩90,095 | ₩92,820 | ₩96,042 |
Now (TTM)
- Market cap
- ₩171B
- Enterprise value
- ₩10B
- P/E
- 3.3×
- P/B
- 0.3×
- P/S
- 0.4×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩22,050 | ₩19,370 | ₩33,000 | ₩33,100 | ₩43,000 |
| Market cap | ₩137B | ₩120B | ₩205B | ₩206B | ₩267B |
| P/E | 4.7× | 4.2× | 4.8× | 6.2× | 5.9× |
| P/B | 0.3× | 0.2× | 0.4× | 0.5× | 0.7× |
| P/S | 0.3× | 0.3× | 0.5× | 0.5× | 0.7× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | 0.0% | — | — | — |
Versus similar companies
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Spigen Korea / 슈피겐코리아 / 192440 / KRX:192440
Source: KRX statistical information